Kaléo has announced plans to offer an authorized generic of its Evzio (naloxone hydrochloride) take-home auto-injector at a list price reportedly 96% lower than the brand, following a public backlash fuelled by America’s deepening opioid public health crisis.
At a list price of US$178 for a two-pack carton, the Virginia-based firm’s authorized generic Evzio product will be offered...



